2019
DOI: 10.1016/j.conctc.2019.100478
|View full text |Cite
|
Sign up to set email alerts
|

Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study

Abstract: BackgroundAttention-Deficit/Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder affecting up to 9% of children and substantial numbers of adults. Existing pharmacologic treatments often improve symptoms, but concerns exist over side effects, stigma, potential long-term health effects, and residual irritability, often treated with adjunctive antipsychotics. To address public and clinician demand for non-pharmacologic evidence-based treatments, this study will examine efficacy of a 36-ingredie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

6
4

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 55 publications
0
7
0
Order By: Relevance
“…In summary, open label pilot studies and two RCTs provide promising data for multinutrient supplementation in ADHD populations. Replication at other geographical centers is underway, with a larger trial of emotionally dysregulated kids with ADHD involving three centers (two in the US and one in Canada) completed in July 2020 (Johnstone et al, 2019); study results are expected in 2021.…”
Section: Adhdmentioning
confidence: 99%
“…In summary, open label pilot studies and two RCTs provide promising data for multinutrient supplementation in ADHD populations. Replication at other geographical centers is underway, with a larger trial of emotionally dysregulated kids with ADHD involving three centers (two in the US and one in Canada) completed in July 2020 (Johnstone et al, 2019); study results are expected in 2021.…”
Section: Adhdmentioning
confidence: 99%
“…The composite CASI score is the planned primary outcome of an RCT currently underway. The Micronutrients for ADHD in Youth (MADDY) study is an 8-week, fully blinded clinical trial recruiting children aged 6-12 years with ADHD and emotional dysregulation ( Johnstone et al 2019) to investigate a broad-spectrum micronutrient supplement (NCT03252522). The MADDY study's primary outcome, designed a priori as a composite score, comprises the five subscales from the CASI-5 (Gadow and Sprafkin 2015), as described in this article.…”
Section: Adhd and Emotional Dysregulation 169 Discussionmentioning
confidence: 99%
“…This qualitative study was a substudy of the Micronutrients for ADHD in Youth (MADDY) study, a three‐site fully‐blinded, randomized controlled trial conducted at the University of Lethbridge, Alberta, Canada; Oregon Health & Science University, Portland, Oregon; and The Ohio State University, Columbus, Ohio. Children aged 6 to 12 years were randomized to a multinutrient supplement (containing all known vitamins and essential minerals, with some antioxidants and amino acids) or a placebo for 8 weeks, followed by an 8‐week open‐label period (Johnstone et al, 2019, 2021). Parents whose children were enrolled in the MADDY study were invited to participate in the qualitative study.…”
Section: Methodsmentioning
confidence: 99%